[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2012 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
06-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- 56.87%
YoY- 73.18%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 1,509,162 1,495,830 1,378,779 1,329,942 1,153,195 1,002,232 976,890 7.51%
PBT 89,005 87,726 59,990 99,066 56,818 48,163 53,948 8.69%
Tax -20,462 -30,122 -24,496 -28,392 -16,215 -15,901 -14,337 6.10%
NP 68,543 57,604 35,494 70,674 40,603 32,262 39,611 9.56%
-
NP to SH 67,982 57,147 34,387 69,645 40,215 32,640 38,279 10.04%
-
Tax Rate 22.99% 34.34% 40.83% 28.66% 28.54% 33.01% 26.58% -
Total Cost 1,440,619 1,438,226 1,343,285 1,259,268 1,112,592 969,970 937,279 7.42%
-
Net Worth 534,070 507,513 473,857 496,623 464,307 424,715 407,610 4.60%
Dividend
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Div 59,542 41,429 25,427 29,420 - 50,281 28,885 12.80%
Div Payout % 87.59% 72.50% 73.95% 42.24% - 154.05% 75.46% -
Equity
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Net Worth 534,070 507,513 473,857 496,623 464,307 424,715 407,610 4.60%
NOSH 258,880 258,935 258,938 117,683 106,983 106,981 106,984 15.86%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin 4.54% 3.85% 2.57% 5.31% 3.52% 3.22% 4.05% -
ROE 12.73% 11.26% 7.26% 14.02% 8.66% 7.69% 9.39% -
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
RPS 582.96 577.69 532.47 1,130.10 1,077.92 936.83 913.11 -7.20%
EPS 26.26 22.07 13.28 59.18 37.59 30.51 35.78 -5.02%
DPS 23.00 16.00 9.82 25.00 0.00 47.00 27.00 -2.63%
NAPS 2.063 1.96 1.83 4.22 4.34 3.97 3.81 -9.71%
Adjusted Per Share Value based on latest NOSH - 117,646
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
RPS 104.71 103.79 95.67 92.28 80.01 69.54 67.78 7.51%
EPS 4.72 3.97 2.39 4.83 2.79 2.26 2.66 10.02%
DPS 4.13 2.87 1.76 2.04 0.00 3.49 2.00 12.83%
NAPS 0.3706 0.3521 0.3288 0.3446 0.3222 0.2947 0.2828 4.60%
Price Multiplier on Financial Quarter End Date
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Date 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 -
Price 6.50 4.63 4.82 7.55 5.90 4.98 4.09 -
P/RPS 1.12 0.80 0.91 0.67 0.55 0.53 0.45 16.40%
P/EPS 24.75 20.98 36.30 12.76 15.70 16.32 11.43 13.73%
EY 4.04 4.77 2.76 7.84 6.37 6.13 8.75 -12.07%
DY 3.54 3.46 2.04 3.31 0.00 9.44 6.60 -9.85%
P/NAPS 3.15 2.36 2.63 1.79 1.36 1.25 1.07 19.70%
Price Multiplier on Announcement Date
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Date 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 13/11/09 -
Price 6.50 4.45 4.72 8.25 5.90 4.92 3.93 -
P/RPS 1.12 0.77 0.89 0.73 0.55 0.53 0.43 17.28%
P/EPS 24.75 20.16 35.54 13.94 15.70 16.13 10.98 14.49%
EY 4.04 4.96 2.81 7.17 6.37 6.20 9.10 -12.65%
DY 3.54 3.60 2.08 3.03 0.00 9.55 6.87 -10.45%
P/NAPS 3.15 2.27 2.58 1.95 1.36 1.24 1.03 20.46%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment